CD34+ hematopoietic stem and progenitor cells from JAK2V617F+ primary myelofibrosis exhibited a greater number of dysregulated genes than those from JAK2V617F+ polycythemia vera and JAK2V617F+ essential thrombocythemia. The gene discussed is CD34; the disease is myelofibrosis.